✦ LIBER ✦

The efficacy and safety of auranofin in the treatment of juvenile rheumatoid arthritis

✍ Scribed by Roberto Marcolongo; Alessandro Mathieu; Riccarda Pala; Nicola Giordano; Antonella Fioravanti; Rita Panzarasa

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 435 KB
Volume: 31
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780310806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy and safety of intraarticula

The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis

✍ Jasper Neidel; Martina Boehnke; R. Michael Küster 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

No firm basis to advocate auranofin in t

No firm basis to advocate auranofin in the treatemnt of juvenile rheumatoid arthritis

✍ Lindsey A. Criswell; Patricia P. Katz; Basia B. Tack; Edward H. Giannini; Earl J 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

Table 1. Characteristics of 10 patients with dermatomyositis treated with cyclosporin A (CsA)\*

The safety and efficacy of leflunomide i

The safety and efficacy of leflunomide in combination with infliximab in rheumatoid arthritis

✍ Hansen, K. E. ;Cush, J. ;Singhal, A. ;A. Cooley, D. ;Cohen, S. ;Patel, S. R. ;Ge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

## Objective: To report the safety and efficacy of leflunomide (lef) in combination with infliximab (inf) for the treatment of rheumatoid arthritis. ## Methods: In an open, multicenter, retrospective study, data were collected on the safety and efficacy of lef and inf. ## Results: Eighty-eight

Safety and efficacy of meningococcal c v

Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis

✍ Evelien Zonneveld-Huijssoon; Arash Ronaghy; Marion A. J. Van Rossum; Ger T. Rijk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 1 views

## Abstract ## Objective To determine whether vaccinations aggravate the course of autoimmune diseases such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations may be hampered by immunosuppressive therapy for the underlying disease. ## Methods In this multicent

Long-term safety and efficacy of etanerc

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis

✍ Daniel J. Lovell; Andreas Reiff; Olcay Y. Jones; Rayfel Schneider; James Nocton; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticular‐course juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye

Safety and efficacy of up to eight years

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

✍ Daniel J. Lovell; Andreas Reiff; Norman T. Ilowite; Carol A. Wallace; Yun Chon; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views